{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T15:09:01Z","timestamp":1775574541469,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,10,28]],"date-time":"2014-10-28T00:00:00Z","timestamp":1414454400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s11739-014-1140-1","type":"journal-article","created":{"date-parts":[[2014,10,27]],"date-time":"2014-10-27T15:58:05Z","timestamp":1414425485000},"page":"829-839","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Amiodarone-related thyroid dysfunction"],"prefix":"10.1007","volume":"9","author":[{"given":"Bartosz","family":"Hudzik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Zubelewicz-Szkodzinska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,28]]},"reference":[{"issue":"4","key":"1140_CR1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1476-5381.1970.tb09891.x","volume":"39","author":"BN Singh","year":"1970","unstructured":"Singh BN, Vaughan Williams EM (1970) The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br J Pharmacol 39(4):657\u2013667","journal-title":"Br J Pharmacol"},{"issue":"4","key":"1140_CR2","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/FJC.0b013e31818914b6","volume":"52","author":"BN Singh","year":"2008","unstructured":"Singh BN (2008) Amiodarone as paradigm for developing new drugs for atrial fibrillation. J Cardiovasc Pharmacol 52(4):300\u2013305. doi: 10.1097\/FJC.0b013e31818914b6","journal-title":"J Cardiovasc Pharmacol"},{"issue":"19","key":"1140_CR3","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1136\/hrt.2008.152652","volume":"96","author":"L Erven van","year":"2010","unstructured":"van Erven L, Schalij MJ (2010) Amiodarone: an effective antiarrhythmic drug with unusual side effects. Heart 96(19):1593\u20131600. doi: 10.1136\/hrt.2008.152652 (pii: 96\/19\/1593)","journal-title":"Heart"},{"issue":"9","key":"1140_CR4","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.hrthm.2007.07.020","volume":"4","author":"N Goldschlager","year":"2007","unstructured":"Goldschlager N, Epstein AE, Naccarelli GV, Olshansky B, Singh B, Collard HR, Murphy E (2007) A practical guide for clinicians who treat patients with amiodarone: 2007. Heart Rhythm 4(9):1250\u20131259. doi: 10.1016\/j.hrthm.2007.07.020","journal-title":"Heart Rhythm"},{"issue":"21","key":"1140_CR5","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","volume":"33","author":"AJ Camm","year":"2012","unstructured":"Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P (2012) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33(21):2719\u20132747. doi: 10.1093\/eurheartj\/ehs253","journal-title":"Eur Heart J"},{"key":"1140_CR6","volume-title":"Comprehensive handbook of iodine : nutritional, biochemical, pathological and therapeutic aspects","author":"VR Preedy","year":"2009","unstructured":"Preedy VR, Burrow GN, Watson RR (2009) Comprehensive handbook of iodine : nutritional, biochemical, pathological and therapeutic aspects. Elsevier, London"},{"issue":"3","key":"1140_CR7","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/cen.12376","volume":"80","author":"B Hudzik","year":"2014","unstructured":"Hudzik B, Zubelewicz-Szkodzinska B (2014) Radiocontrast-induced thyroid dysfunction: is it common and what should we do about it? Clin Endocrinol (Oxf) 80(3):322\u2013327. doi: 10.1111\/cen.12376","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"1140_CR8","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1210\/jcem-62-3-563","volume":"62","author":"RH Rao","year":"1986","unstructured":"Rao RH, McCready VR, Spathis GS (1986) Iodine kinetic studies during amiodarone treatment. J Clin Endocrinol Metab 62(3):563\u2013568. doi: 10.1210\/jcem-62-3-563","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1140_CR9","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.beem.2009.07.001","volume":"23","author":"SA Eskes","year":"2009","unstructured":"Eskes SA, Wiersinga WM (2009) Amiodarone and thyroid. Best Pract Res Clin Endocrinol Metab 23(6):735\u2013751. doi: 10.1016\/j.beem.2009.07.001","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"5","key":"1140_CR10","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/MED.0b013e3283565bb2","volume":"19","author":"AM Leung","year":"2012","unstructured":"Leung AM, Braverman LE (2012) Iodine-induced thyroid dysfunction. Curr Opin Endocrinol Diabetes Obes 19(5):414\u2013419. doi: 10.1097\/MED.0b013e3283565bb2","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"1","key":"1140_CR11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nrendo.2009.225","volume":"6","author":"J Cohen-Lehman","year":"2010","unstructured":"Cohen-Lehman J, Dahl P, Danzi S, Klein I (2010) Effects of amiodarone therapy on thyroid function. Nat Rev Endocrinol 6(1):34\u201341. doi: 10.1038\/nrendo.2009.225 (pii: nrendo.2009.225)","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"1140_CR12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2165\/00003088-198409020-00002","volume":"9","author":"R Latini","year":"1984","unstructured":"Latini R, Tognoni G, Kates RE (1984) Clinical pharmacokinetics of amiodarone. Clin Pharmacokinet 9(2):136\u2013156. doi: 10.2165\/00003088-198409020-00002","journal-title":"Clin Pharmacokinet"},{"issue":"11","key":"1140_CR13","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1001\/jama.298.11.1312","volume":"298","author":"P Vassallo","year":"2007","unstructured":"Vassallo P, Trohman RG (2007) Prescribing amiodarone: an evidence-based review of clinical indications. JAMA 298(11):1312\u20131322. doi: 10.1001\/jama.298.11.1312","journal-title":"JAMA"},{"issue":"5","key":"1140_CR14","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2125.2009.03381.x","volume":"67","author":"C Lafuente-Lafuente","year":"2009","unstructured":"Lafuente-Lafuente C, Alvarez JC, Leenhardt A, Mouly S, Extramiana F, Caulin C, Funck-Brentano C, Bergmann JF (2009) Amiodarone concentrations in plasma and fat tissue during chronic treatment and related toxicity. Br J Clin Pharmacol 67(5):511\u2013519. doi: 10.1111\/j.1365-2125.2009.03381.x","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"1140_CR15","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0735-1097(87)80320-0","volume":"9","author":"ML Greenberg","year":"1987","unstructured":"Greenberg ML, Lerman BB, Shipe JR, Kaiser DL, DiMarco JP (1987) Relation between amiodarone and desethylamiodarone plasma concentrations and electrophysiologic effects, efficacy and toxicity. J Am Coll Cardiol 9(5):1148\u20131155","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"1140_CR16","doi-asserted-by":"crossref","first-page":"E817","DOI":"10.1503\/cmaj.101800","volume":"183","author":"MA Tsadok","year":"2011","unstructured":"Tsadok MA, Jackevicius CA, Rahme E, Essebag V, Eisenberg MJ, Humphries KH, Tu JV, Behlouli H, Joo J, Pilote L (2011) Amiodarone-induced thyroid dysfunction: brand-name versus generic formulations. CMAJ 183(12):E817\u2013E823. doi: 10.1503\/cmaj.101800","journal-title":"CMAJ"},{"issue":"2","key":"1140_CR17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/hrt.79.2.121","volume":"79","author":"CM Newman","year":"1998","unstructured":"Newman CM, Price A, Davies DW, Gray TA, Weetman AP (1998) Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy. Heart 79(2):121\u2013127","journal-title":"Heart"},{"issue":"5","key":"1140_CR18","first-page":"269","volume":"10","author":"S Ursella","year":"2006","unstructured":"Ursella S, Testa A, Mazzone M, Gentiloni Silveri N (2006) Amiodarone-induced thyroid dysfunction in clinical practice. Eur Rev Med Pharmacol Sci 10(5):269\u2013278","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"1140_CR19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1210\/jcem.82.1.3675","volume":"82","author":"G Iervasi","year":"1997","unstructured":"Iervasi G, Clerico A, Bonini R, Manfredi C, Berti S, Ravani M, Palmieri C, Carpi A, Biagini A, Chopra IJ (1997) Acute effects of amiodarone administration on thyroid function in patients with cardiac arrhythmia. J Clin Endocrinol Metab 82(1):275\u2013280. doi: 10.1210\/jcem.82.1.3675","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1140_CR20","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.amjmed.2004.11.028","volume":"118","author":"S Basaria","year":"2005","unstructured":"Basaria S, Cooper DS (2005) Amiodarone and the thyroid. Am J Med 118(7):706\u2013714 (pii: S0002-9343(05)00219-6)","journal-title":"Am J Med"},{"issue":"3","key":"1140_CR21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/2042018811398516","volume":"2","author":"SK Narayana","year":"2011","unstructured":"Narayana SK, Woods DR, Boos CJ (2011) Management of amiodarone-related thyroid problems. Ther Adv Endocrinol Metab 2(3):115\u2013126. doi: 10.1177\/2042018811398516","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"3","key":"1140_CR22","first-page":"340","volume":"35","author":"F Bogazzi","year":"2012","unstructured":"Bogazzi F, Tomisti L, Bartalena L, Aghini-Lombardi F, Martino E (2012) Amiodarone and the thyroid: a 2012 update. J Endocrinol Invest 35(3):340\u2013348. doi: 10.3275\/8298","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"1140_CR23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7326\/0003-4819-101-1-28","volume":"101","author":"E Martino","year":"1984","unstructured":"Martino E, Safran M, Aghini-Lombardi F, Rajatanavin R, Lenziardi M, Fay M, Pacchiarotti A, Aronin N, Macchia E, Haffajee C et al (1984) Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann Intern Med 101(1):28\u201334","journal-title":"Ann Intern Med"},{"issue":"5","key":"1140_CR24","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1365-2265.2008.03268.x","volume":"69","author":"ML Tanda","year":"2008","unstructured":"Tanda ML, Piantanida E, Lai A, Liparulo L, Sassi L, Bogazzi F, Wiersinga WM, Braverman LE, Martino E, Bartalena L (2008) Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists. Clin Endocrinol (Oxf) 69(5):812\u2013818. doi: 10.1111\/j.1365-2265.2008.03268.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"1140_CR25","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0002-9343(91)90187-3","volume":"91","author":"MD Trip","year":"1991","unstructured":"Trip MD, Wiersinga W, Plomp TA (1991) Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. Am J Med 91(5):507\u2013511","journal-title":"Am J Med"},{"issue":"5","key":"1140_CR26","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/105072501300176462","volume":"11","author":"K Markou","year":"2001","unstructured":"Markou K, Georgopoulos N, Kyriazopoulou V, Vagenakis AG (2001) Iodine-Induced hypothyroidism. Thyroid 11(5):501\u2013510. doi: 10.1089\/105072501300176462","journal-title":"Thyroid"},{"key":"1140_CR27","volume-title":"The Merck manual of diagnosis and therapy","author":"RS Porter","year":"2011","unstructured":"Porter RS, Kaplan JL (2011) The Merck manual of diagnosis and therapy, 19th edn. Merck Sharp & Dohme, Whitehouse Station","edition":"19"},{"issue":"893","key":"1140_CR28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/pmj.76.893.133","volume":"76","author":"KC Loh","year":"2000","unstructured":"Loh KC (2000) Amiodarone-induced thyroid disorders: a clinical review. Postgrad Med J 76(893):133\u2013140","journal-title":"Postgrad Med J"},{"issue":"6","key":"1140_CR29","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/BF03346400","volume":"31","author":"F Bogazzi","year":"2008","unstructured":"Bogazzi F, Bartalena L, Tomisti L, Dell\u2019Unto E, Cosci C, Sardella C, Tanda ML, Lai A, Gasperi M, Aghini-Lombardi F, Martino E (2008) Potassium perchlorate only temporarily restores euthyroidism in patients with amiodarone-induced hypothyroidism who continue amiodarone therapy. J Endocrinol Invest 31(6):515\u2013519 (pii: 4635)","journal-title":"J Endocrinol Invest"},{"key":"1140_CR30","volume-title":"Pharmacotherapeutics of the thyroid gland. Handbook of experimental pharmacology","author":"JW Barlow","year":"1997","unstructured":"Barlow JW, Weetman AP, Grossman A (1997) Pharmacotherapeutics of the thyroid gland. Handbook of experimental pharmacology, vol 128. Springer, Berlin"},{"issue":"5","key":"1140_CR31","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/MED.0b013e328357271a","volume":"19","author":"MB Zimmermann","year":"2012","unstructured":"Zimmermann MB, Andersson M (2012) Update on iodine status worldwide. Curr Opin Endocrinol Diabetes Obes 19(5):382\u2013387. doi: 10.1097\/MED.0b013e328357271a","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"1140_CR32","volume-title":"iodine deficiency in Europe: a continuing public helath problem","author":"M Andersson","year":"2007","unstructured":"Andersson M, de Benoist B, Darnton-Hill I, Delange F (2007) iodine deficiency in Europe: a continuing public helath problem. World Health Organization, Geneva"},{"issue":"7","key":"1140_CR33","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3949\/ccjm.70.7.624","volume":"70","author":"GA Cardenas","year":"2003","unstructured":"Cardenas GA, Cabral JM, Leslie CA (2003) Amiodarone induced thyrotoxicosis: diagnostic and therapeutic strategies. Cleve Clin J Med 70(7):624\u2013626 (628\u2013631)","journal-title":"Cleve Clin J Med"},{"issue":"Suppl 1","key":"1140_CR34","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1007\/s11739-013-0913-2","volume":"8","author":"A Carpi","year":"2013","unstructured":"Carpi A, Cini G, Russo M, Antonelli A, Gaudio C, Galetta F, Franzoni F, Rossi G (2013) Subclinical hyperthyroidism and cardiovascular manifestations: a reevaluation of the association. Intern Emerg Med 8(Suppl 1):S75\u2013S77. doi: 10.1007\/s11739-013-0913-2","journal-title":"Intern Emerg Med"},{"issue":"4","key":"1140_CR35","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1530\/EJE-08-0348","volume":"159","author":"M Piga","year":"2008","unstructured":"Piga M, Cocco MC, Serra A, Boi F, Loy M, Mariotti S (2008) The usefulness of 99mTc-sestaMIBI thyroid scan in the differential diagnosis and management of amiodarone-induced thyrotoxicosis. Eur J Endocrinol 159(4):423\u2013429. doi: 10.1530\/EJE-08-0348","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"1140_CR36","first-page":"213","volume":"33","author":"M Piga","year":"2008","unstructured":"Piga M, Serra A, Boi F, Tanda ML, Martino E, Mariotti S (2008) Amiodarone-induced thyrotoxicosis. A review. Minerva Endocrinol 33(3):213\u2013228","journal-title":"Minerva Endocrinol"},{"issue":"3","key":"1140_CR37","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/EJE-14-0267","volume":"171","author":"L Tomisti","year":"2014","unstructured":"Tomisti L, Rossi G, Bartalena L, Martino E, Bogazzi F (2014) The onset time of amiodarone-induced thyrotoxicosis (AIT) depends on AIT type. Eur J Endocrinol 171(3):363\u2013368. doi: 10.1530\/EJE-14-0267","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"1140_CR38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1210\/jc.2008-1907","volume":"94","author":"KH Yiu","year":"2009","unstructured":"Yiu KH, Jim MH, Siu CW, Lee CH, Yuen M, Mok M, Shea YF, Fan K, Tse HF, Chow WH (2009) Amiodarone-induced thyrotoxicosis is a predictor of adverse cardiovascular outcome. J Clin Endocrinol Metab 94(1):109\u2013114. doi: 10.1210\/jc.2008-1907","journal-title":"J Clin Endocrinol Metab"},{"issue":"43\u201344","key":"1140_CR39","first-page":"579","volume":"133","author":"C Rajeswaran","year":"2003","unstructured":"Rajeswaran C, Shelton RJ, Gilbey SG (2003) Management of amiodarone-induced thyrotoxicosis. Swiss Med Wkly 133(43\u201344):579\u2013585","journal-title":"Swiss Med Wkly"},{"issue":"6","key":"1140_CR40","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1210\/jc.2010-0180","volume":"95","author":"F Bogazzi","year":"2010","unstructured":"Bogazzi F, Bartalena L, Martino E (2010) Approach to the patient with amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 95(6):2529\u20132535. doi: 10.1210\/jc.2010-0180","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1140_CR41","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0828-282X(09)70512-4","volume":"25","author":"W Tsang","year":"2009","unstructured":"Tsang W, Houlden RL (2009) Amiodarone-induced thyrotoxicosis: a review. Can J Cardiol 25(7):421\u2013424","journal-title":"Can J Cardiol"},{"issue":"5","key":"1140_CR42","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0002-9343(97)00047-8","volume":"102","author":"G Dickstein","year":"1997","unstructured":"Dickstein G, Shechner C, Adawi F, Kaplan J, Baron E, Ish-Shalom S (1997) Lithium treatment in amiodarone-induced thyrotoxicosis. Am J Med 102(5):454\u2013458","journal-title":"Am J Med"},{"issue":"3","key":"1140_CR43","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2125.1991.tb05548.x","volume":"31","author":"B Uzzan","year":"1991","unstructured":"Uzzan B, Pussard E, Leon A, Bekhechi D, Krivitzky A, Modigliani E, Perret G, Vassy R, Berdeaux A, Giudicelli JF (1991) The effects of plasmapheresis on thyroid hormone and plasma drug concentrations in amiodarone-induced thyrotoxicosis. Br J Clin Pharmacol 31(3):371\u2013372","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"1140_CR44","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1444-0903.2004.00600.x","volume":"34","author":"TH Diamond","year":"2004","unstructured":"Diamond TH, Rajagopal R, Ganda K, Manoharan A, Luk A (2004) Plasmapheresis as a potential treatment option for amiodarone-induced thyrotoxicosis. Intern Med J 34(6):369\u2013370. doi: 10.1111\/j.1444-0903.2004.00600.x","journal-title":"Intern Med J"},{"issue":"5","key":"1140_CR45","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/jca.20143","volume":"22","author":"D Shemin","year":"2007","unstructured":"Shemin D, Briggs D, Greenan M (2007) Complications of therapeutic plasma exchange: a prospective study of 1,727 procedures. J Clin Apher 22(5):270\u2013276. doi: 10.1002\/jca.20143","journal-title":"J Clin Apher"},{"issue":"11","key":"1140_CR46","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1210\/jc.2011-1678","volume":"96","author":"F Bogazzi","year":"2011","unstructured":"Bogazzi F, Bartalena L, Tomisti L, Rossi G, Brogioni S, Martino E (2011) Continuation of amiodarone delays restoration of euthyroidism in patients with type 2 amiodarone-induced thyrotoxicosis treated with prednisone: a pilot study. J Clin Endocrinol Metab 96(11):3374\u20133380. doi: 10.1210\/jc.2011-1678","journal-title":"J Clin Endocrinol Metab"},{"key":"1140_CR47","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4137\/CMC.S6677","volume":"5","author":"GV Naccarelli","year":"2011","unstructured":"Naccarelli GV, Wolbrette DL, Levin V, Samii S, Banchs JE, Penny-Peterson E, Gonzalez MD (2011) Safety and efficacy of dronedarone in the treatment of atrial fibrillation\/flutter. Clin Med Insights Cardiol 5:103\u2013119. doi: 10.4137\/CMC.S6677","journal-title":"Clin Med Insights Cardiol"},{"issue":"5","key":"1140_CR48","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s10557-009-6189-0","volume":"23","author":"K Yalta","year":"2009","unstructured":"Yalta K, Turgut OO, Yilmaz MB, Yilmaz A, Tandogan I (2009) Dronedarone: a promising alternative for the management of atrial fibrillation. Cardiovasc Drugs Ther 23(5):385\u2013393. doi: 10.1007\/s10557-009-6189-0","journal-title":"Cardiovasc Drugs Ther"},{"issue":"3","key":"1140_CR49","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jacc.2006.04.072","volume":"48","author":"C Ypenburg","year":"2006","unstructured":"Ypenburg C, van Erven L, Bleeker GB, Bax JJ, Bootsma M, Wijffels MC, van der Wall EE, Schalij MJ (2006) Benefit of combined resynchronization and defibrillator therapy in heart failure patients with and without ventricular arrhythmias. J Am Coll Cardiol 48(3):464\u2013470","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1140_CR50","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1365-2265.2004.02119.x","volume":"61","author":"L Bartalena","year":"2004","unstructured":"Bartalena L, Wiersinga WM, Tanda ML, Bogazzi F, Piantanida E, Lai A, Martino E (2004) Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association. Clin Endocrinol (Oxf) 61(4):494\u2013502","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"1140_CR51","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.jp.7211104","volume":"24","author":"JP Lomenick","year":"2004","unstructured":"Lomenick JP, Jackson WA, Backeljauw PF (2004) Amiodarone-induced neonatal hypothyroidism: a unique form of transient early-onset hypothyroidism. J Perinatol 24(6):397\u2013399. doi: 10.1038\/sj.jp.7211104 (pii: 7211104)","journal-title":"J Perinatol"},{"issue":"2","key":"1140_CR52","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/BF03343825","volume":"24","author":"L Bartalena","year":"2001","unstructured":"Bartalena L, Bogazzi F, Braverman LE, Martino E (2001) Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment. J Endocrinol Invest 24(2):116\u2013130","journal-title":"J Endocrinol Invest"},{"issue":"12","key":"1140_CR53","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1503\/cmaj.100351","volume":"183","author":"C Mackenzie","year":"2011","unstructured":"Mackenzie C, Syed J, Pollak PT, Koren G (2011) Falling between the cracks: a case of amiodarone toxicity. CMAJ 183(12):1393\u20131397. doi: 10.1503\/cmaj.100351","journal-title":"CMAJ"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-014-1140-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11739-014-1140-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-014-1140-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T21:28:50Z","timestamp":1559424530000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11739-014-1140-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,28]]},"references-count":53,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1140"],"URL":"https:\/\/doi.org\/10.1007\/s11739-014-1140-1","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,28]]}}}